Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To plan ahead for inventory purposes
— Pharmacy purchaser, USA
To be aware of drugs likely to come off patent soon to help budget
— Hospital pharmacist, UK
To know patent expiration dates for different drugs
— Physician, Hungary
To know which brands are on and off patent
— Advertising sales pharma companies, USA
To know about pharmaceutical patents and their expiration dates
— Pharmaceutical R&D, Venezuela
Generated: May 25, 2017
| Tradename: | 1 |
| Applicant: | 1 |
| Ingredient: | 1 |
| Patents: | 1 |
| Formulation / Manufacturing: | see details |
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 25MG ACID/PACKET | ||||
| Approval Date: | Aug 24, 2015 | TE: | RLD: | Yes | |||||
| Patent: | 7,452,874 | Patent Expiration: | May 24, 2021 | Product Flag? | Y | Substance Flag? | Y | Delist Request? | |
| Regulatory Exclusivity Expiration: | Jun 11, 2018 | ||||||||
| Regulatory Exclusivity Use: | DOSING INFORMATION ADDED TO THE LABELING REGARDING PEDIATRIC PATIENTS 6 YEARS AND OLDER WITH ITP | ||||||||
| Regulatory Exclusivity Expiration: | Jun 11, 2018 | ||||||||
| Regulatory Exclusivity Use: | INCLUSION OF PEDIATRIC PATIENTS AGES 6 YRS AND OLDER FOR THE TREATMENT OF THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC ITP WHO HAVE HAD AN INSUFFICIENT RESPONSE TO CORTICOSTEROIDS, IMMUNOGLOBULINS, OR SPLENECTOMY. | ||||||||
For access to patents for competitive analysis and project managment
— Pharmaceutical industry consultant, USA
To identify patent expiry dates for Canada and the USA
— Pharmacy services, Canada
To get information about data exclusivity, basic and constraining patents in the United States and Europe
— Business development manager, Turkey
To obtain patent expiration information, so that the timeline for registration and launch of our generic products can be optimized.
— Business development manager, generics distribution company, Singapore
To check for drug patent status in MENA
— Pharmaceutical manufacturer, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
